Source
Author: unknown
Eli Lilly to buy genetic medicine developer Akouos for $487 million [Deals Market Headlines | Breaking Stock Market News | Reuters]
Related Posts
KKR, Temasek look to buy India’s TPG-backed Care Hospitals [Private Equity Insights]
U.S. investment firm KKR, Singapore’s Temasek Holdings, and India’s Max Healthcare Institute are vying to buy TPG-backed chain of Care Hospitals in a deal worth over $1bn, Mint newspaper...
Humana, CVS Circle Cano Health as Potential Buyers [Deals – News, Articles, Biography, Photos – WSJ.com]
Cano shares, which had been down nearly 7%, turned positive and closed up 32% after The Wall Street Journal reported on the talks with Humana and other unnamed parties, giving the company a market...
Pfizer Completes Acquisition of Global Blood Therapeutics [Business Wire Merger/Acquisition News]
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the discovery,...
AstraZeneca pays 660% premium for gene therapy firm LogicBio [Deals Market Headlines | Breaking Stock Market News | Reuters]
Oct 3 (Reuters) - Shares of LogicBio Therapeutics (LOGC.O) skyrocketed on Monday after Britain's AstraZeneca's (AZN.L) said it would buy the U.S.-based gene therapy developer at a rare 660% premium...